NetworkNewsBreaks – Aethlon Medical, Inc. (NASDAQ: AEMD) Establishes Large-Scale Production Collaboration with iBio, Inc. (NYSE: IBIO)
Aethlon Medical (NASDAQ: AEMD) this morning said that it has established a collaboration with iBio, Inc. (NYSE AMERICAN: IBIO) to support potential large-scale production of the Aethlon Hemopurifier®. The companies intend to advance large-scale production of a recombinant form of Galanthus nivalis agglutinin (GNA), a plant-derived lectin that is immobilized within the Hemopurifier® to bind infectious enveloped viruses. Aethlon has completed a feasibility study with iBio researchers confirming the capability to produce highly active recombinant GNA through the use of iBio's plant-based technology. "The production of recombinant GNA in iBio's large-scale manufacturing facilities establishes a pathway for us to access…







